Key terms

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest DXCM news

Mar 26 4:47am ET Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM) Mar 25 9:56am ET Early notable gainers among liquid option names on March 25th Mar 18 5:55am ET TipRanks’ ‘Perfect 10’ List: Analysts Pound the Table on These Top-Scoring Stocks Mar 12 9:51am ET Oracle, Dollar General upgraded: Wall Street’s top analyst calls Mar 12 6:28am ET RBC starts DexCom with Outperform on multi-year runway Mar 12 5:25am ET Wells Fargo Remains a Buy on Dexcom (DXCM) Mar 12 5:05am ET DexCom initiated with an Outperform at RBC Capital Mar 11 1:10am ET Analysts Are Bullish on These Healthcare Stocks: Wave Life Sciences (WVE), Dexcom (DXCM) Mar 06 9:55am ET Early notable gainers among liquid option names on March 6th Mar 06 7:35am ET Piper Sandler Sticks to Its Buy Rating for Dexcom (DXCM) Mar 06 6:27am ET Dexcom’s Stelo Launch Fuels Buy Rating on Expansive Market Opportunity Mar 06 6:02am ET DexCom’s (NASDAQ:DXCM) Stelo Becomes the First Glucose Monitor to be Cleared for OTC Use Mar 06 6:01am ET Analysts Conflicted on These Healthcare Names: AMN Healthcare Services (AMN) and Dexcom (DXCM) Mar 05 9:31pm ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Orthofix (OFIX) and Medtronic (MDT) Mar 05 4:27pm ET DexCom announces FDA clears Stelo biosensor Mar 05 5:31am ET DexCom announces new CGM data, direct to Apple Watch functionality in Q2 Mar 01 2:25pm ET DexCom call volume above normal and directionally bullish Mar 01 7:50am ET Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS), Azitra Inc (AZTR) and Dexcom (DXCM) Feb 15 4:40pm ET Dexcom Finalizes Stock Warrant Termination and Equity Deals Feb 14 12:58pm ET Coleman’s Tiger Global bought Broadcom and DexCom during Q4 Feb 13 6:00am ET Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Dexcom (DXCM) and Tenaya Therapeutics (TNYA) Feb 13 5:10am ET Dexcom: A Strong Buy on Robust Performance and Growth Prospects Feb 12 3:51am ET Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS), Dexcom (DXCM) and Gilead Sciences (GILD) Feb 10 1:00am ET A New Cause for Concern: Dexcom Adds a New Natural and Human Disruptions Risk Feb 09 8:01am ET Analysts Are Bullish on Top Healthcare Stocks: Denali Therapeutics (DNLI), Illumina (ILMN) Feb 09 7:51am ET DexCom price target raised to $160 from $110 at TD Cowen Feb 09 7:31am ET DexCom price target raised to $144 from $140 at Canaccord Feb 08 10:05pm ET Dexcom’s Strong Performance and Expansion Strategies Merit a Buy Rating Feb 08 4:03pm ET DexCom backs FY24 revenue roughly $4.15B-$4.35B, consensus $4.33B Feb 08 4:03pm ET DexCom reports Q4 adjusted EPS 50c, consensus 43c Feb 08 2:49pm ET DexCom options imply 6.6% move in share price post-earnings

No recent press releases are available for DXCM

DXCM Financials

1-year income & revenue

Key terms

DXCM Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

DXCM Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms